Clinical trial comparing Lipegfilgrastim to Filgrastim in Pediatric Patients Diagnosed with Ewing Family of Tumors or Rhabdomyosarcoma Receiving Chemotherapy

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000087-34

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to assess the efficacy of a single subcutaneous (sc) dose of 100 μg/kg body weight (BW) of lipegfilgrastim per cycle compared to daily 5 μg/kg BW of filgrastim doses in children receiving CTX


Critère d'inclusion

  • Neutropenia in pediatric patients diagnosed with Ewing family of Tumors
  • or rhabdomyosarcoma receiving chemotherapy